Adcy7 Protein — Adenylate Cyclase 7 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Adenylate Cyclase 7 |
|---|
| Protein Name | ADCY7 (Adenylyl Cyclase 7) |
| Gene | ADCY7 |
| UniProt ID | P51828 |
| Protein Family | Adenylate cyclase family (Class III) |
| Molecular Weight | ~130 kDa |
| Expression | Brain (high in cerebellum, hippocampus), immune cells |
ADCY7 (Adenylate Cyclase 7) is a membrane-bound enzyme that catalyzes the conversion of ATP to cyclic AMP (cAMP), a crucial second messenger in cellular signaling. ADCY7 is one of nine mammalian adenylate cyclase isoforms, each with distinct regulatory properties and expression patterns. ADCY7 is particularly abundant in the brain and immune system.
ADCY7 is a large transmembrane protein consisting of:
- N-terminal extracellular domain: Involved in regulation
- Two transmembrane domains: Each with 6 transmembrane helices
- Two cytoplasmic catalytic domains (C1a, C2a): Form the cAMP synthesis pocket
- Regulatory domains: Contain binding sites for forskolin, Gαs, and Gβγ
The enzyme is activated by Gαs subunits and forskolin, while Gαi subunits inhibit activity. Gβγ complexes can either stimulate or inhibit depending on the isoform and cellular context.
ADCY7 produces cAMP in response to:
- Gαs-coupled receptor activation: Including dopamine D1 receptors, β-adrenergic receptors, and serotonin receptors
- Forskolin direct activation: Bypassing receptor signaling
- Gβγ modulation: Can enhance or inhibit activity
cAMP generated by ADCY7 is essential for:
- Long-term potentiation (LTP): PKA-dependent synaptic strengthening
- Memory formation: cAMP/PKA/CREB signaling cascade
- Gene expression regulation: CREB-mediated transcription
ADCY7-derived cAMP modulates:
- Ion channel function: PKA phosphorylation of channels
- Transporter activity: Regulation of neurotransmitter reuptake
- Second messenger crosstalk: Interaction with Ca²⁺ and MAPK pathways
ADCY7 is implicated in amyloid-beta pathophysiology:
- cAMP dysregulation: Aβ reduces ADCY7 activity, impairing cAMP signaling
- Synaptic failure: Disrupted cAMP/PKA signaling contributes to synaptic dysfunction
- Memory deficits: Impaired CREB-mediated gene expression affects memory consolidation
- Tau pathology: cAMP signaling interacts with tau phosphorylation pathways
Dopaminergic signaling relies on adenylate cyclase activity:
- D1 receptor signaling: ADCY7 mediates D1 receptor-dependent cAMP production
- D2 receptor inhibition: Gαi-mediated inhibition affects D2 signaling
- Neuroprotection: cAMP-activated pathways can protect dopaminergic neurons
- L-DOPA response: Adenylate cyclase activity influences levodopa efficacy
ADCY7 is a potential therapeutic target:
- Phosphodiesterase inhibitors: Enhance cAMP signaling by preventing degradation
- ADCY7 modulators: Direct activators or inhibitors of ADCY7
- cAMP analogs: Pharmacological approaches to bypass defective adenylate cyclase
ADCY7 is highly expressed in immune cells:
- B cell activation: cAMP signaling modulates antibody production
- T cell function: Regulates T cell activation and cytokine production
- Inflammation: Modulates inflammatory responses relevant to neuroinflammation
Polymorphisms in ADCY7 have been associated with:
- Neuropsychiatric disorders: Schizophrenia, depression
- Immune dysfunction: Autoimmune conditions
- Metabolic effects: cAMP regulation of glucose metabolism
The study of Adcy7 Protein — Adenylate Cyclase 7 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Hanoune & Defer, Regulation and role of adenylyl cyclase isoforms (2001)
- Dessauer, Adenylyl cyclase - A and C (2007)
- Ferguson, G protein-coupled receptor signaling in the CNS (2001)